Imai Aki | Department Of Discovery Biology Research Global Research & Development Nagoya Laboratories Pfize
スポンサーリンク
概要
- Imai Akiの詳細を見る
- 同名の論文著者
- Department Of Discovery Biology Research Global Research & Development Nagoya Laboratories Pfizeの論文著者
関連著者
-
Imai Aki
Department Of Discovery Biology Research Global Research & Development Nagoya Laboratories Pfize
-
Hirao Akiko
Department Of Biology Graduate School Of Science Osaka University
-
Sugie Yutaka
Department Of Discovery Biology Research Global Research & Development Nagoya Laboratories Pfize
-
Toide Katsuo
Department Of Discovery Biology Research Global Research & Development Nagoya Laboratories Pfize
-
Yamada Yoshinari
Department Of Discovery Biology Research Global Research & Development Nagoya Laboratories Pfize
-
Hayashi Shigeo
Department Of Applied Physecs And Chemistry University Of Electro-communications
-
HAYASHI Shigeo
Department of Applied Physics and Chemistry, University of Electro-Communications
-
TAKENAKA Hiroshi
Department of Earth and Planetary Sciences, Kyushu University
-
Sugahara Yazuyuki
Dep. Of Lab. Medicine Nagasaki Univ. Graduate School Of Biomedical Sciences Nagasaki Univ. Hospital
-
Imai Aki
京都薬科大学 薬理
-
Imai Aki
Department Of Pharmacology Kyoto Pharmaceutical University
-
Asaka Masahiro
Department Of Gastroenterology And Hematology Hokkaido University Graduate School Of Medicine
-
Shimizu Yuichi
Department Of Science And Engineering For Materials Tomakomai National College Of Technology
-
Kato Mototsugu
Division Of Endoscopy Hokkaido University Hospital
-
ONO SHOUKO
Division of Endoscopy, Hokkaido University Hospital
-
Mizutani Nobuaki
Department of Pharmacology, Kobe Pharmaceutical University, Japan
-
Shimizu Yuichi
Department Of Electrical And Electronic Engineering Musashi Institute Of Technology
-
Hirao Akiko
Department of Clinical Pharmacology and Therapeutics, Hamamatsu University School of Medicine
-
Asaka Masahiro
Third Department Of Internal Medicine Hokkaido University Graduate School Of Medicine
-
NABE Takeshi
Department of Pharmacology, Kyoto Pharmaceutical University
-
KOHNO Shigekatsu
Department of Pharmacology, Kyoto Pharmaceutical University
-
Yamamoto Keiko
Department Of Geophysics Graduate School Of Science Kyoto University Kyoto Japan
-
ASAKA Rumiko
Department of Gastroenterology, Hokkaido University Graduate School of Medicine
-
NISHIDA Urara
Department of Gastroenterology, Hokkaido University Graduate School of Medicine
-
YOSHIDA Takeshi
Department of Gastroenterology, Hokkaido University Graduate School of Medicine
-
MAKIYAMA Hiroaki
Department of Gastroenterology, Hokkaido University Graduate School of Medicine
-
Maruta Ichiroh
Department Of Hematology And Oncology Hokkaido University Graduate School Of Medicine
-
Kato Mototsugu
Division Of Endoscopy Hokkaido University Medical Hospital
-
SUGIE Yutaka
Department of Discovery Biology Research, Global Research & Development, Nagoya Laboratories, Pfizer
-
YAMADA Yoshinari
Department of Discovery Biology Research, Global Research & Development, Nagoya Laboratories, Pfizer
-
TOIDE Katsuo
Department of Discovery Biology Research, Global Research & Development, Nagoya Laboratories, Pfizer
-
Hirao Akiko
Department Of Discovery Biology Research Global Research & Development Nagoya Laboratories Pfize
-
SAKURAI Hiromu
Analytical and Bioinorganic Chemistry, Kyoto Pharmaceutical University
-
Takenaka Hiroshi
Department Of Otolaryngology Osaka Medical College
-
Takenaka Hiroshi
Department Of Otorhinolaryngology Osaka Medical College
-
Imamura Masahiro
Department Of Internal Medicine Saiseikai-hita Hospital
-
Nabe Takeshi
Department Of Pharmacology Kyoto Pharmaceutical University:department Of Pneumology Ogaki Municipal
-
Nabe Takeshi
Department Of Pharmacology Kyoto Pharmaceutical University
-
Takenaka H
Kyushu Univ.
-
Asaka Masahiro
Hokkaido Univ. School Of Medicine Sapporo Jpn
-
Yoshida Takeshi
Department Of Epidemiology Medical Research Institute Tokyo Medical And Dental University
-
Makiyama Hiroaki
Department Of Gastroenterology Hokkaido University Graduate School Of Medicine
-
Takenaka Hiroshi
Department Of Earth And Planetary Sciences Kyushu University
-
Kohno Shigekatsu
Department Of Pharmacology Division Of Pathological Sciences Kyoto Pharmaceutical University
-
Mizutani Nobuaki
Department Of Pharmacology Kobe Pharmaceutical University
-
Yamamoto Keiko
Department Of Basic Allied Medicine School Of Health Sciences Gunma University
-
Takenaka Hiroshi
Department Of Chemistry Faculty Of Science Osaka City University
-
Kato Mototsugu
Department Of Endoscopy Hokkaido University Hospital
-
Asaka M
Department Of Gastroenterology Hokkaido University Graduate School Of Medicine
-
Sakurai Hiromu
Analytical And Bioinorganic Chemistry Kyoto Pharmaceutical University
-
Hayashi Shigeo
Department Of Discovery Chemistry Research Global Research & Development Nagoya Laboratories Pfi
-
Hayashi Shigeo
Department Of Applied Physics And Chemistry The University Of Electro-communications
-
Yoshida Takeshi
Department Of Biochemistry Hokkaido University School Of Dentistry
-
Nabe T
Department Of Pharmacology Kyoto Pharmaceutical University
-
Asaka Masahiro
Department Of Cancer Preventive Medicine Graduate School Of Medicine Hokkaido University
-
Yoshida Takeshi
Department of Applied Physics, Graduate School of Engineering, Osaka University, Suita, Osaka 565-0871, Japan
-
Yoshida Takeshi
Department of Applied Chemistry, Faculty of Engineering, Kanagawa University
-
Hayashi Shigeo
Department of Discovery Chemistry Research, Global Research & Development, Nagoya Laboratories, Pfizer Inc., Japan
-
Sugie Yutaka
Department of Discovery Biology Research, Global Research & Development, Nagoya Laboratories, Pfizer Inc., Japan
-
Makiyama Hiroaki
Department of Gastroenterology and Hepatology, Kitami Red Cross Hospital, Japan
著作論文
- INVESTIGATION OF LOW-DOSE ASPIRIN-INDUCED GASTRODUODENAL DAMAGE ACCORDING TO H. PYLORI INFECTION STATUS
- Pharmacological Characterization of the Newly Synthesized Nociceptin/Orphanin FQ-Receptor Agonist 1-[1-(1-Methylcyclooctyl)-4-piperidinyl]-2-[(3R)-3-piperidinyl]-1H-benzimidazole as an Anxiolytic Agent
- Markedly Increased Nasal Blockage by Intranasal Leukotriene D_4 in an Experimental Allergic Rhinitis Model: Contribution of Dilated Mucosal Blood Vessels
- Pharmacological Characterization of the Newly Synthesized Nociceptin/Orphanin FQ–Receptor Agonist 1-[1-(1-Methylcyclooctyl)-4-piperidinyl]-2-[(3R)-3-piperidinyl]-1H-benzimidazole as an Anxiolytic Agent